EOM Pharmaceuticals (OTCMKTS:IMUC) Stock Price Up 49.3% – Here’s What Happened

EOM Pharmaceuticals Holdings, Inc. ( OTCMKTS:IMUC – Get Free Report ) rose 49.3% during trading on Monday .

The stock traded as high as $0.20 and last traded at $0.20.



Approximately 10,443 shares traded hands during trading, an increase of 239% from the average daily volume of 3,085 shares. The stock had previously closed at $0.13.

EOM Pharmaceuticals Trading Up 49.3 % The firm has a 50-day moving average of $0.13 and a two-hundred day moving average of $0.

15. EOM Pharmaceuticals Company Profile ( Get Free Report ) Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.

Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. Featured Stories Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .

.